SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yohei Shirakami, Seung-Ah Lee, Robin D. Clugston, William S. Blaner, Hepatic metabolism of retinoids and disease associations, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012, 1821, 1, 124

    CrossRef

  2. 2
    Hae-Ki Min, Ashwani Kapoor, Michael Fuchs, Faridoddin Mirshahi, Huiping Zhou, James Maher, John Kellum, Russell Warnick, Melissa J. Contos, Arun J. Sanyal, Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease, Cell Metabolism, 2012, 15, 5, 665

    CrossRef

  3. 3
    Patrick Mougenot, Claudie Namane, Eykmar Fett, Florence Camy, Rommel Dadji-Faïhun, Gwladys Langot, Catherine Monseau, Bénédicte Onofri, François Pacquet, Cécile Pascal, Olivier Crespin, Majdi Ben-Hassine, Jean-Luc Ragot, Thao Van-Pham, Christophe Philippo, Florence Chatelain-Egger, Philippe Péron, Jean-Christophe Le Bail, Etienne Guillot, Philippe Chamiot-Clerc, Marie-Aude Chabanaud, Marie-Pierre Pruniaux, Friedemann Schmidt, Olivier Venier, Eric Nicolaï, Fabrice Viviani, Thiadiazoles as new inhibitors of diacylglycerol acyltransferase type 1, Bioorganic & Medicinal Chemistry Letters, 2012, 22, 7, 2497

    CrossRef

  4. 4
    Aparajita Dey, S. Mathan Kumar, Cytochrome P450 2E1 and hyperglycemia-induced liver injury, Cell Biology and Toxicology, 2011, 27, 4, 285

    CrossRef

  5. 5
    Jacquelyn J. Maher, New Insights from Rodent Models of Fatty Liver Disease, Antioxidants & Redox Signaling, 2011, 15, 2, 535

    CrossRef

  6. 6
    Rosanne M Crooke, Mark J Graham, Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia, Clinical Lipidology, 2011, 6, 6, 675

    CrossRef

  7. You have free access to this content7
    Junpei Iwasa, Masahito Shimizu, Makoto Shiraki, Yohei Shirakami, Hiroyasu Sakai, Yoichi Terakura, Koji Takai, Hisashi Tsurumi, Takuji Tanaka, Hisataka Moriwaki, Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice, Cancer Science, 2010, 101, 2
  8. 8
    Michael Trauner, Marco Arrese, Martin Wagner, Fatty liver and lipotoxicity, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010, 1801, 3, 299

    CrossRef

  9. 9
    Christopher D Byrne, Fatty liver: Role of inflammation and fatty acid nutrition, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2010, 82, 4-6, 265

    CrossRef

  10. 10
    An Afida Ashla, Yoshiko Hoshikawa, Hiroyuki Tsuchiya, Koich Hashiguchi, Munechika Enjoji, Makoto Nakamuta, Akinobu Taketomi, Yoshihiko Maehara, Kohei Shomori, Akihiro Kurimasa, Ichiro Hisatome, Hisao Ito, Goshi Shiota, Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease, Hepatology Research, 2010, 40, 6
  11. 11
    Peng Chen, Zheyi Han, Ping Yang, Lin Zhu, Zichun Hua, Jianfa Zhang, Loss of clock gene mPer2 promotes liver fibrosis induced by carbon tetrachloride, Hepatology Research, 2010, 40, 11
  12. 12
    Karen M Kassel, Grace L Guo, Ossama Tawfik, James P Luyendyk, Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine–choline-deficient diet, Laboratory Investigation, 2010, 90, 12, 1794

    CrossRef

  13. 13
    Wing-Kin Syn, Steve S. Choi, Anna Mae Diehl, Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis, Clinics in Liver Disease, 2009, 13, 4, 565

    CrossRef

  14. 14
    Jingjing Jiao, Scott L Friedman, Costica Aloman, Hepatic fibrosis, Current Opinion in Gastroenterology, 2009, 25, 3, 223

    CrossRef

  15. 15
    P. Tessari, A. Coracina, A. Cosma, A. Tiengo, Hepatic lipid metabolism and non-alcoholic fatty liver disease, Nutrition, Metabolism and Cardiovascular Diseases, 2009, 19, 4, 291

    CrossRef

  16. 16
    Angela Dolganiuc, Jan Petrasek, Karen Kodys, Donna Catalano, Pranoti Mandrekar, Arumugam Velayudham, Gyongyi Szabo, MicroRNA Expression Profile in Lieber-DeCarli Diet-Induced Alcoholic and Methionine Choline Deficient Diet-Induced Nonalcoholic Steatohepatitis Models in Mice, Alcoholism: Clinical and Experimental Research, 2009, 33, 10
  17. 17
    Onpan Cheung, Arun J Sanyal, Recent advances in nonalcoholic fatty liver disease, Current Opinion in Gastroenterology, 2009, 25, 3, 230

    CrossRef

  18. 18
    Claudio J. Villanueva, Mara Monetti, Michelle Shih, Ping Zhou, Steve M. Watkins, Sanjay Bhanot, Robert V. Farese, Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids, Hepatology, 2009, 50, 2
  19. 19
    Arumugam Velayudham, Angela Dolganiuc, Michael Ellis, Jan Petrasek, Karen Kodys, Pranoti Mandrekar, Gyongyi Szabo, VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice, Hepatology, 2009, 49, 3
  20. 20
    Mohamed H. Ahmed, Christopher D. Byrne, Non-Alcoholic Fatty Liver Disease,